Researchers develop bifunctional cancer cell-based vaccine to simultaneously kill and prevent brain cancer Dr. Kamal Kant Kohli7 Jan 2023 9:30 AM ISTUsing gene engineering, the researchers are repurposing cancer cells to develop a therapeutic that kills tumor cells and stimulates the immune system...
COVID-19 vaccines, prior infection reduce transmission of Omicron Dr. Kamal Kant Kohli6 Jan 2023 8:00 PM ISTStudy in California Prisons Found Recent Vaccination and Boosters Reduce Infectiousness, but Infection Risk Remains High.Vaccination and boosting,...
Lumpy skin disease vaccine: Govt collaborates with Institute of Veterinary Biological Products for commercial production of Lumpi-ProVac Ruchika Sharma2 Jan 2023 11:35 AM ISTLumpi-ProVac is used for the prophylactic immunization of animals against lumpy skin disease which gives protection for about one year.
Ebola vaccine regimens safe, immunogenic in adults and children Dr. Kamal Kant Kohli2 Jan 2023 10:00 AM ISTTwo randomized, placebo-controlled trials evaluating three Ebola vaccine administration strategies in adults and children found that all the regimens...
Novavax begins Phase 2 trial for COVID-Influenza Combo, influenza stand-alone vaccines Ruchika Sharma1 Jan 2023 11:30 AM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
3 months of waiting after infection to get booster COVID19 shot can maximize increase in antibody levels Dr.Niharika Harsha B31 Dec 2022 11:30 AM ISTA new study found that a waiting period of 3 months for the third dose of mRNA vaccine elicits robust humoral immune response among those who...
Pfizer Pentavalent Meningococcal Vaccine under USFDA review Ruchika Sharma31 Dec 2022 10:00 AM ISTPfizer’s MenABCWY vaccine candidate combines the components of two vaccines into one, helping protect against the meningococcal serogroups that cause...
COVID-19 Update: Health Ministry informs about steps taken for containment and management Kajal Rajput30 Dec 2022 12:45 PM ISTNew Delhi: As the year 2022 ends, the Health Ministry has informed about the proactive steps consistently being taken to respond to the COVID-19...
Coronavirus vaccine: SII to give 2 crore Covishield doses worth Rs 410 crore to Central govt free of cost Ruchika Sharma29 Dec 2022 11:15 AM ISTAmid a spike in COVID-19 cases in some countries, including China and South Korea, the government has sounded an alert and asked states and Union...
Bharat Biotech, Biological E together hold about 250 million COVID vaccine doses Ruchika Sharma28 Dec 2022 2:43 PM ISTBharat Biotech sources said the vaccine maker has more than 50 million doses of Covaxin readily available in vials, and over 200 million doses as drug...
Aurobindo Pharma JV Tergene gets CDSCO panel recommendation for 15-valent Pneumococcal Polysaccharide Conjugate Vaccine Ruchika Sharma27 Dec 2022 3:42 PM ISTHyderabad: Drugmaker, Aurobindo Pharma Ltd, has announced that Subject Expert Committee (SEC) of the Central Drugs StandardControl Organization...
COVID intranasal vaccine: Bharat Biotech iNCOVACC priced at Rs 800 for private hospitals, Rs 325 for Govt Ruchika Sharma27 Dec 2022 2:30 PM ISTiNCOVACC is the world's first intranasal vaccine for COVID to receive approval for the primary two-dose schedule, and as a heterologous booster dose.
